Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Augmentin XR Will Be Available In Mid-October, Priced At $9 Per Day

Executive Summary

GlaxoSmithKline will launch its latest addition to the Augmentin family of products in mid-October following FDA's Sept. 25 approval of Augmentin XR
Advertisement

Related Content

GSK’s X-Factor: Augmentin XR, Other Line Extensions Key To Growth
GSK’s X-Factor: Augmentin XR, Other Line Extensions Key To Growth
Geneva Generic Augmentin Distribution Limited To Warehousing Drug Chains
Geneva Generic Augmentin Distribution Limited To Warehousing Drug Chains
Advertisement
UsernamePublicRestriction

Register

PS040543

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel